Clinical studies support its efficacy in reducing melanin production and improving hyperpigmentation
AOD-9604 was advanced through Phase I and Phase II clinical trials by Metabolic Pharmaceuticals between roughly 2003 and 2007 enrolling approximately 900 participants in total
By Ross Pelton, RPh, PhD, CCN Scientific Director, Essential Formulas Glutathione is the most prevalent antioxidant in the body and a key regulator of detoxification
These fine needles cause minimal sensation and are appropriate for the small volumes involved in peptide administration
Lead Researcher Spotlight Professor Predrag Sikiric, MD, PhD Department of Pharmacology University of Zagreb School of Medicine, Zagreb, Croatia Professor Predrag Sikiric has been the primary investigator for BPC-157 research since the 1990s, establishing the foundational research base for one of the key components in KLOW Blend